{
    "clinical_study": {
        "@rank": "137793", 
        "arm_group": {
            "arm_group_label": "Everolimus", 
            "arm_group_type": "Experimental", 
            "description": "Patients who are receiving everolimus in a Novartis-sponsored, Oncology Clinical Development & Medical Affairs (CD&MA) study that has reached its study objectives, are not progressing on the current study treatment as defined by the parent protocol and are unable to access everolimus treatment outside of a clinical trial will be allowed to enroll. If patients are receiving treatment of everolimus in combination with other approved therapies, they can participate in the roll-over study, but it is not intended for combination with unapproved or experimental treatments.  Patients who meet all inclusion and none of the exclusion criteria will be treated with the same daily everolimus dose they are receiving in the parent protocol until disease progression (as defined in the parent protocol), unacceptable toxicity develops, consent withdrawl, protocol non-compliance, the investigator feels it is no longer in the patient's best interest to continue therapy, or the patient's death."
        }, 
        "brief_summary": {
            "textblock": "Study to allow access to everolimus for patients who are on everolimus treatment in a\n      Novartis-sponsored study and are benefiting from the treatment as judged by the investigator"
        }, 
        "brief_title": "Everolimus Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Everolimus Study.", 
        "completion_date": {
            "#text": "September 2022", 
            "@type": "Anticipated"
        }, 
        "condition": "Neoplasms", 
        "condition_browse": {
            "mesh_term": "Neoplasms"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patient is currently enrolled in a Novartis-sponsored, CD&MA study receiving\n             everolimus or everolimus plus Sandostatin LAR Depot and has fulfilled all their\n             requirements in the parent study\n\n          -  Patient is currently benefiting from treatment with everolimus, as determined by the\n             guidelines of the parent protocol.\n\n        Exclusion Criteria:\n\n          -  Patient has been permanently discontinued from everolimus study treatment in the\n             parent study.\n\n          -  Patient is receiving everolimus in combination with an unapproved or experimental\n             treatment\n\n          -  Other protocol-defined inclusion/exclusion criteria may apply"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "31", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 7, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01789281", 
            "org_study_id": "CRAD001C2X01B"
        }, 
        "intervention": [
            {
                "arm_group_label": "Everolimus", 
                "description": "Everolimus will be provided by the investigator in 2.5 mg, 5 mg or 10 mg tablets for daily oral administration. Everolimus can be provided as local commercial material or global supply where appropriate", 
                "intervention_name": "Everolimus", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Everolimus", 
                "description": "Patients receiving everolimus treatment in combination with Sandostatin LAR Depot on the parent protocol will be allowed to continue Sandostatin LAR Depot treatment. Sandostatin LAR Depot will continue to be provided by Novartis or by the investigational site considering local regulations. The dose and frequency of Sandostatin LAR Intramuscular injections will be administered at the discretion of the treating physician.", 
                "intervention_name": "Sandostatin LAR Depot", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Octreotide", 
                "Lactitol", 
                "Sirolimus", 
                "Everolimus"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": "Neoplasms, Carcinoid tumor, Neuroendocrine tumor", 
        "lastchanged_date": "March 13, 2014", 
        "location": [
            {
                "contact": {
                    "email": "crandall@carti.com", 
                    "last_name": "Carla Randall", 
                    "phone": "501-320-3217"
                }, 
                "facility": {
                    "address": {
                        "city": "Little Rock", 
                        "country": "United States", 
                        "state": "Arkansas", 
                        "zip": "72205"
                    }, 
                    "name": "Hematology Oncology Services of Arkansas SC"
                }, 
                "investigator": {
                    "last_name": "Brad Baltz", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "katherine.schleich@usoncology.com", 
                    "last_name": "Katherine Schleich", 
                    "phone": "303-730-4751"
                }, 
                "facility": {
                    "address": {
                        "city": "Greenwood Village", 
                        "country": "United States", 
                        "state": "Colorado"
                    }, 
                    "name": "Rocky Mountain Cancer Centers SC"
                }, 
                "investigator": {
                    "last_name": "Richard McMahon", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "dfowler@stamhealth.org", 
                    "last_name": "Debra Flower", 
                    "phone": "203-276-8447"
                }, 
                "facility": {
                    "address": {
                        "city": "Stamford", 
                        "country": "United States", 
                        "state": "Connecticut", 
                        "zip": "06902"
                    }, 
                    "name": "Stamford Hospital"
                }, 
                "investigator": {
                    "last_name": "Salvatore DelPrete", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tampa", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33612"
                    }, 
                    "name": "H. Lee Moffitt Cancer Center & Research Institute SC-2"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "contact": {
                    "email": "YLafary@IUHealth.org", 
                    "last_name": "Yvonne LaFary", 
                    "phone": "317-678-2739"
                }, 
                "facility": {
                    "address": {
                        "city": "Indianapolis", 
                        "country": "United States", 
                        "state": "Indiana", 
                        "zip": "46227"
                    }, 
                    "name": "Central Indiana Cancer Centers SC"
                }, 
                "investigator": {
                    "last_name": "Hillary Wu", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "vdavis@wjmc.org", 
                    "last_name": "Vivian Davis", 
                    "phone": "504-454-5368"
                }, 
                "facility": {
                    "address": {
                        "city": "Metairie", 
                        "country": "United States", 
                        "state": "Louisiana", 
                        "zip": "70006"
                    }, 
                    "name": "Crescent City Research Consortium, LLC SC-3"
                }, 
                "investigator": {
                    "last_name": "Thomas Cosgriff", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "Rogne.steven@mayo.edu", 
                    "last_name": "Steve Rogne", 
                    "phone": "507-266-5027"
                }, 
                "facility": {
                    "address": {
                        "city": "Rochester", 
                        "country": "United States", 
                        "state": "Minnesota", 
                        "zip": "55905"
                    }, 
                    "name": "Mayo Clinic - Rochester SC-2"
                }, 
                "investigator": {
                    "last_name": "Timothy Hobday", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "abolden@dom.wustl.edu", 
                    "last_name": "Ashley Bolden", 
                    "phone": "314-747-8085"
                }, 
                "facility": {
                    "address": {
                        "city": "St. Louis", 
                        "country": "United States", 
                        "state": "Missouri", 
                        "zip": "63110"
                    }, 
                    "name": "Washington University School Of Medicine-Siteman Cancer Ctr Dept of Oncology"
                }, 
                "investigator": {
                    "last_name": "Joel Picus", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "Molly.davis@alegent.org", 
                    "last_name": "Molly Davis", 
                    "phone": "402-717-4714"
                }, 
                "facility": {
                    "address": {
                        "city": "Omaha", 
                        "country": "United States", 
                        "state": "Nebraska", 
                        "zip": "68154"
                    }, 
                    "name": "Nebraska Cancer Specialists/Alegent Health Once Dept."
                }, 
                "investigator": {
                    "last_name": "Ralph Hauke", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "hansedan@ohsu.edu", 
                    "last_name": "Daniel Hansen", 
                    "phone": "503-494-3078"
                }, 
                "facility": {
                    "address": {
                        "city": "Portland", 
                        "country": "United States", 
                        "state": "Oregon", 
                        "zip": "97239"
                    }, 
                    "name": "Oregon Health & Science University SC-8"
                }, 
                "investigator": {
                    "last_name": "Rodney Pommier", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dallas", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "75246"
                    }, 
                    "name": "US Oncology Central Monitoring"
                }, 
                "status": "Withdrawn"
            }, 
            {
                "contact": {
                    "email": "clarsen@utahcancer.com", 
                    "last_name": "Casey Larsen", 
                    "phone": "801-281-6863"
                }, 
                "facility": {
                    "address": {
                        "city": "Salt Lake City", 
                        "country": "United States", 
                        "state": "Utah", 
                        "zip": "84106"
                    }, 
                    "name": "Utah Cancer Specialists Utah Cancer (2)"
                }, 
                "investigator": {
                    "last_name": "S. DiSean Kendall", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Norfolk", 
                        "country": "United States", 
                        "state": "Virginia", 
                        "zip": "23502"
                    }, 
                    "name": "Virginia Oncology Associates SC"
                }, 
                "status": "Withdrawn"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Praha 2", 
                        "country": "Czech Republic", 
                        "zip": "128 08"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Avignon Cedex", 
                        "country": "France", 
                        "zip": "84082"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chambray-l\u00e8s-Tours", 
                        "country": "France", 
                        "zip": "37170"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lyon", 
                        "country": "France", 
                        "zip": "69437"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Montpellier Cedex 5", 
                        "country": "France", 
                        "zip": "34298"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rouen Cedex", 
                        "country": "France", 
                        "zip": "76031"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Berlin", 
                        "country": "Germany", 
                        "zip": "13353"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Withdrawn"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Milano", 
                        "country": "Italy", 
                        "state": "MI", 
                        "zip": "20133"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Groningen", 
                        "country": "Netherlands", 
                        "zip": "9713 GZ"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sevilla", 
                        "country": "Spain", 
                        "state": "Andalucia", 
                        "zip": "41013"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Czech Republic", 
                "France", 
                "Germany", 
                "Italy", 
                "Netherlands", 
                "Spain"
            ]
        }, 
        "number_of_arms": "1", 
        "official_title": "An Open-label, Multi-center Everolimus Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Everolimus Study and Are Judged by the Investigator to Benefit From Continued Everolimus Treatment", 
        "overall_contact": {
            "last_name": "Novartis Pharmaceuticals", 
            "phone": "1-888-669-6682"
        }, 
        "overall_contact_backup": {
            "last_name": "Novartis Pharmaceuticals", 
            "phone_ext": "+41613241111"
        }, 
        "overall_official": {
            "affiliation": "Novartis Pharmaceuticals", 
            "last_name": "Novartis Pharmaceuticals", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "June 2022", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Number of patients receiving everolimus", 
            "safety_issue": "No", 
            "time_frame": "10 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01789281"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Number of patients experiencing serious adverse events", 
            "safety_issue": "Yes", 
            "time_frame": "10 years"
        }, 
        "source": "Novartis", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Novartis Pharmaceuticals", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "May 2013", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}